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Suspensions  of intact  animal cells are capable  of 
transferring the sugar moiety of exogenous nucleo- 
tide sugars to endogenous glycoprotein and glyco- 
lipid acceptors (10,  12,  13).  It has frequently been 
assumed  that  incorporation  by  suspended  cells 
incubated  with  nucleotidr  sugars  indicates  the 
presence  of  an  ectoglycosyltransferase.  Ectoen- 
zymes  are  defined  as  membrane-bound  enzymes 
whose active sites are accessible from the outside 
of the cell (3). 
Several recent publications  have challenged the 
suggestion  that  glycosyltransferases  are  ectoen- 
zymes. Evans found a  nucleotide pyrophosphatase 
on  the  plasma  membrane  of  hepatocytes  which 
could degrade exogenously added nucleotide-sugar 
substrates  (5).  Deppert  et  al.  (4)  have  reported 
evidence that  all the  incorporation  by baby  ham- 
ster kidney (BHK) monolayers  is due to hydrolysis 
and  intraceilular  utilization  of the labeled  galac- 
tose  released  by degradation  of exogenous UDP- 
galactose. 
In  this  communication,  we  show  that  while 
suspensions of mouse spleen cells incorporate label 
from exogenous UDP-[l~C]galactose, there are no 
ectogalactosyltransferases.  The  spleen cell prepa- 
rations  degrade  the  nucleotide  sugar,  releasing 
galactose  which  is  utilized  for complex carbohy- 
drate  synthesis  within  the  cell.  In  contrast, 
BALB/c 3T3 and simian virus 40-transformed 3T3 
cells  in  suspension  possess  an  ectogalactosyl- 
transferase  capable  of transferring  the  carbohy- 
drate  moiety  of  exogenous  UDP-galactose  to 
endogenous acceptor molecules. 
MATERIALS  AND  METHODS 
Cell Cultures 
BALB/c  3T3  cells  (clone  A31)  and  simian  virus 
40-transformed 3T3 cells (SVT2) were the gift of Dr. G. 
Todaro,  National  Institutes  of Health,  Bcthesda,  Md. 
The  procedures  for  fibroblast  growth  and  suspension 
using  0.01 M  EDTA in saline for studies  of r 
tosyltransferases have been described (10). 
Cells were teased out of spleens from BALB/c or C3H 
mice  into  Hanks'  balanced  salts  solution  with  0.6% 
dextran (HBSS +  dex). Cells were dispersed  by express- 
ing through a 20-G needle. They were then washed twice 
with  HBSS  +  dex  and  resuspcnded  in  RPMI  1640 
medium  supplemented  with  5%  fresh  human  serum,  2 
mM  glutamine,  40  U/ml  penicillin,  and  50  ~g/ml 
streptomycin.  Suspensions  were  diluted  to  5  ￿  106 
mononuclear cells per milliliter and 2-ml aliquots were 
placed  in  17  ￿  100-ram  plastic  culture  tubes  (Falcon 
Plastics, Oxnard, Calif.). Concanavalin A (Con A) 1 from 
Calbiochem  (San  Diego,  Calif.)  was  added  in  0.2-ml 
aliquots of a  100 ~g/ml solution (final concentration  l0 
/~g/ml).  Incubation was carried out for 48 h at 37~  in a 
humidified atmosphere of 5% CO2 in air. The 48-h point 
coincides  with  the  maximum  rate  of  [SH]thymidinc 
incorporation.  After  Con  A  stimulation,  cells  were 
centrifuged, resuspended,  and washed  once with TBS. 
Measurement  of galactose  incorporation  into  acid- 
precipitable  material  was  performed  essentially as de- 
scribed  (10). The incubations with lymphocyte or fibro- 
blast cell suspensions  contained 80 pmol UDP-[I'C]ga  - 
lactose,  80  pmol  [SH]galactose,  0.5  ~mol MnCls,  and 
1-3 ￿  106 cells in a final volume of 0.06 ml of TBS. We 
have  previously  reported  the  optimal  reaction  condi- 
tions and kinetic constants for reactions of cell suspen- 
sions with nucleotide sugars (10). 
For experiments  requiring the addition  of unlabeled 
galactose,  galactose-l-phosphate,  and  UDP-galactosr 
solutions  were  prepared  in  TBS  at  concentrations 
10-10,000  times that of the labeled compound. A volume 
of the unlabeled solution  containing the required concen- 
tration  of  inhibitor  was  then  added  to  the  standard 
incubations as described  above. 
Chromatography 
Aliquots of the  supernatant  solutions  from  the  first 
trichloroacetic acid wash  were subjected  to descending 
paper chromatography  on  Whatman  No.  1 paper. The 
solvent system  used  was  95% ethanol-I  M  ammonium 
acetate, pH 3.6 (75:30). The chromatograms were devel- 
oped for 17  20 h. Before spotting on the paper strips,  the 
aliquots were made 20-50 mM in EDTA and neutralized 
with additions of 2.5 N  NaOH. 
The addition of EDTA is necessary  to prevent forma- 
l Abbreviations used in this paper: Con A, concanavalin 
A;  Y-AMP,  adenosine-5'-monophosphoric  acid;  TBS, 
iris-buffered saline, 0.15 M NaCI and 0.02 M Tris-HCl, 
pH 7.4. 
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Mn ~- ions. This complex runs in the solvent used with an 
Rgal of 0.9 and can cause high estimates of the extent of 
nucleotide sugar decomposition. Standards were detected 
with a periodate-permanganate  spray (9). 
Determination  of Radioactivity 
All samples were dissolved in  10 ml of a scintillation 
fluid composed  of xylene, 2,900 ml; Triton X-114, 960 
ml;  and  Liquifluor  (New  England  Nuclear,  Boston, 
Mass.),  125  ml.  Vials also contained  1 ml  10%  acetic 
acid. Counting efficiency was 67% for ~'C and 33% for 
8H. 
Chemicals 
U DP-[~'C]galactose (281 mCi/mmol) and [S~]galac- 
tose (2.04 Ci/mmol) were purchased frorfi New England 
Nuclear.  The  [SH]galactose was  diluted  to  a  specific 
activity  of  250  mCi/mmol  with  unlabeled  galactose 
before  use. UDP-galactose,  galactose-l-phosphate, ga- 
lactose,  and  5'-adenosine  monophosphate  were pur- 
chased from Sigma Chemical Co., St. Louis, Mo. 
RESULTS 
Suspensions  of  BALB/c  fibroblasts  and  spleen 
lymphocytes  incorporate  radioactivity into  acid- 
precipitable material when  incubated with  UDP- 
[t4C]galactose. Adding Con A  to spleen lympho- 
cytes results in a fivefold stimulation of incorpora- 
tion, with a maximum effect at 48 h. The increase 
in  UDP-[l*C]galactose utilization coincides with 
the  peak  of  [3H]thymidine  incorporation.  The 
results  from  these  lymphocyte experiments  con- 
firm those from experiments on rat thymocytes in 
which Con A-stimulated blast transformation also 
resulted in increased galactose incorporation from 
exogenous UDP-galactose (8). We initiated studies 
to  determine  whether  the  incorporation  into 
lymphocytes and fibroblasts was due to substrate 
degradation or ectogalactosyltransferases. 
Table  I  shows  the  results of an  experiment in 
which unlabeled UDP-galactose, galactose-l-PO4, 
and galactose were added to suspensions of fibro- 
blasts or Con  A-stimulated spleen cells incubated 
with equal concentrations of UDP-[~*C]galactose 
and  [SH]galactose. The  UDP-[t4C]galactose  was 
intended  to  measure  ectoenzyme  activity;  the 
[aH]galactose was included to measure intracellu- 
lar activity. The addition of unlabeled UDP-galac- 
tose to suspended As~ cells decreased the incorpo- 
ration of radioactivity from the UDP-[~C]galac  - 
tose and had little effect on the incorporation from 
[SH]galaetose. The addition of unlabeled galactose 
had  the  opposite effect.  The  incorporation  from 
the  UDP-[l~]galactose  was  lowered  much  less 
than  that  from  the  [SH]galactose.  In  a  separate 
experiment, the  addition of unlabeled galactose- 
l-phosphate  had  no  effect  on  the  incorporation 
from either compound. 
The  results  with  suspensions of Con  A-stimu- 
lated spleen cells were quite different. The incor- 
poration  of radioactivity from  UDP-[~C]galac- 
tose  and  [SH]galactose was  inhibited to  roughly 
the same extent by the addition of unlabeled UDP- 
galactose,  galactose-l-phosphate,  and  galactose. 
The inhibition of incorporation from UDP-[~C]- 
galactose by unlabeled galactose indicates that the 
nucleotide sugar does not serve as a direct glycose 
donor in the spleen cell suspensions. Also, the in- 
hibition of [SH]galactose incorporation by UDP- 
galactose and galactose-l-phosphate suggests that 
these compounds may be extensively degraded by 
the spleen cell preparations. 
It has  been  reported that  Y-AMP  is  a  potent 
inhibitor of nucleotid  e  sugar hydrolysis (1,  2,  6). 
Table II shows the effect of the addition of a low 
concentration of 5'-AMP on the incorporation of 
radioactivity into  acid-precipitable material  and 
on the decomposition of UDP-[:~C]galactose. The 
inhibition  of  UDP-galactose  hydrolysis  in  the 
fibroblast suspensions  resulted  in  an  increase  in 
incorporation  from  the  nucleotide  sugar,  again 
suggesting  that  the  UDP-galactose  is  the  direct 
glycose donor.  The  spleen cell suspensions show 
the opposite effect. Inhibition of UDP-[~C]galac- 
tose decomposition completely prevents incorpora- 
tion  into acid-precipitable material. These results 
show  that  UDP-[~C]galactose  must  be  broken 
down to the free sugar before it can be utilized by 
the spleen cells. 
Additional information  about  the  pathway  for 
incorporation of galactose from exogenous UDP- 
galactose was obtained from analyses of the prod- 
ucts formed in the  reactions. Strong acid hydrol- 
ysis of the acid-precipitable material from spleen 
cells incubated with UDP-[t'C]galactose yielded a 
mixture of labeled galactose and glucose, indicat- 
ing that the labeled sugar was exposed to the action 
of  intracellular  enzymes  before  incorporation. 
Acid hydrolysis of the  products  from  fibroblast 
incubations yields only labeled galactose. 
DISCUSSION 
Ectoglycosyltransferases have usually been studied 
by incubating intact cells with  nucleotide sugars. 
Our  results  establish  controls  which  can  show 
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Effect of  Addition of Unlabeled U  DP-galactose, Galactose-l-Phosphate, and Galactose on 
Incorporation form UDP-[:'C]Galactose and [:H]Galaetose by Suspensions of A31 and 
Con A-Stimulated Spleen Cells 
Cell  Total incorporation 
type  Addition  Concentration  :4  C  aH 
mM  cpm  cpm 
Spleen  none  --  880 •  70  800 .4- 50 
cells  UDP-Gal  0.1  80 •  4  250 •  10 
GaI-I-PO4  0.1  110 .4- 2  120 .4- 10 
Galactose  0.1  105 -4- 20  90 .4- 10 
A31  (A) none  --  1,640 .4- 40  1,080 .4- 20 
cells  UDP-Gal  1.1  60 .4- 10  760 •  30 
Galactose  12.5  1,270 + 40  120 .4- 10 
(B) none  --  1,290 .4- 40  1,340 .4- 60 
Gal-I-PO,  1.1  1,220 .4- 100  1,010 .4- 70 
Incubations were done as described in Materials and Methods. Reactions contained 1.6  x  10  e 
suspended A3 l cells or 4.7 ￿  l0  s Con A-stimulated spleen cells. Incorporation is .4- the standard 
deviation. 
TABLE  II 
Effect of 5 mM 5'-AMP on the Hydrolysis of UDP-[:*C]Galactose and Incorporation into 
Acid-Precipitable Material 
Percent of radioactivity  as 
Cell 
type  Y-AMP  UDP-Gal  GaI-I-PO,  Gal  Total incorporation 
cpm 
A31  --  32  63  6  1.970 •  100 
+  93  3  4  2,730 •  110 
SVT2  --  29  65  6  880 .4- 20 
+  89  9  2  1,120 .4- 130 
Spleen  --  30  13  34  880 .4- 70 
+ Con A  +  96  4  --  20 .4- 10 
Incubations were set up as described in Materials and Methods. Reactions contained 0.7  x  106 A31 ceils, 3 ￿  10  e 
SVT2 cells, or 4.7 ￿  106 Con A-stimulated spleen ceils. Reactions with 5'-AMP received 5,1 of a solution of  0.075 M 
5'-AMP. Chromatography was performed as described in Materials and Methods. 
whether  incorporation  stems  from  ectoglycosyl- 
transferases or  uptake  and  incorporation  of the 
released free sugar.  First, it is important to show 
that excess unlabeled galactose in quantities suffi- 
cient to inhibit [SH]galactose incorporation has no 
effect on  UDP-[:'C]galactose incorporation. The 
unlabeled  galactose concentration (10  mM)  used 
was  approximately  five  times  the  Km  of  sugar 
transport  reported  for  many  cells  (7,  11,  14). 
Second,  adding  5'-AMP  to  reduce  nucleotide 
sugar  degradation  should  not  inhibit  incorpora- 
tion.  Finally,  the  incorporated  sugar  should  not 
have been altered by cellular metabolism. 
The  results from studies of spleen lymphocytes 
and  fibroblasts  demonstrate  how  these  controls 
differentiate  between  substrate  degradation  and 
ectogalactosyltransferases.  Our  results  indicate 
that suspended fibroblasts but not spleen lympho- 
cytes possess ectoglycosyltransferases. 
SUMMARY 
In this communication, we have demonstrated that 
hydrolysis of the nucleotide sugar can cause errors 
in  the  detection  of  an  ectoglycosyltransferase. 
Spleen cell suspensions can incorporate radioactiv- 
BglEF  NOTES  801 ity  when  incubated  with  labeled  UDP-galactose, 
but all the activity is due to decomposition of the 
nucleotide sugar and uptake of the free sugar. The 
fibroblast cell lines can  incorporate carbohydrate 
directly from  UDP-galactose.  Several criteria are 
presented  with can  be used  to demonstrate that a 
nucleotide sugar is the direct carbohydrate donor. 
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